Svinningegarden

Business news, market intelligence, and global industry analysis.

The Latest

Representative image of resistant hypertension screening and cortisol-related disease, illustrating Corcept Therapeutics’ MOMENTUM trial findings on hypercortisolism prevalence in difficult-to-treat blood pressure patients.

Corcept Therapeutics (NASDAQ: CORT) puts resistant hypertension in the cortisol spotlight with new MOMENTUM trial data

Representative image of the United States Capitol as the Department of Homeland Security shutdown fight deepens, with the House passing a 60-day funding bill that Senate Democrats say they will block.

DHS shutdown set to drag on as House sends Senate a bill Democrats vow to block

Representative image of oral hidradenitis suppurativa treatment research as Incyte Corporation reports positive 54-week povorcitinib Phase 3 data, highlighting the race to expand HS therapy options.

Incyte (NASDAQ: INCY) moves closer to an hidradenitis suppurativa launch as 54-week povorcitinib data hold up

Devdutt Padikkal scores fastest IPL fifty as RCB crush SRH in IPL 2026 season opener

Microsoft Denmark East launch unlocks EU data sovereignty cloud for Danish finance, health, and public sectors

Microsoft opens Denmark East datacenter region as MSFT (NASDAQ) trades near 52-week low amid AI spending scrutiny

Microsoft's Denmark East region opens with EU data residency, zero-water cooling, and 130 MW renewable capacity. Here's what it means for cloud and MSFT.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

March 29, 2026